Turn Therapeutics (TTRX) Operating Expenses (2024 - 2026)

Turn Therapeutics' Operating Expenses history runs 3 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 223.68% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $5.7 million (changed N/A YoY), while the FY2025 annual figure was $5.9 million, up 226.0% from the prior year.
• Operating Expenses was $1.2 million for Q1 2026 at Turn Therapeutics, down from $2.2 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.2 million in Q4 2025 to a low of $328957.0 in Q4 2024.
• Historically, Operating Expenses has averaged $1.1 million across 3 years, with a median of $959567.5 in 2024.
• Biggest YoY gain for Operating Expenses was 566.83% in 2025; the steepest drop was 184.34% in 2025.
• A 3-year view of Operating Expenses shows it stood at $328957.0 in 2024, then soared by 566.83% to $2.2 million in 2025, then sank by 43.19% to $1.2 million in 2026.
• The last three Operating Expenses figures came in at $1.2 million (Q1 2026), $2.2 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.